Author, year | N | Chemotherapy regimen | Conversion rate | Complete resection rate | ||
n | Percent | n | Percent | |||
Wein A, 2001 | 53 | Infusional FU/LV | 9 | 17 | 6 | 11 |
Adam R, 2004 | 1104 | FU/LV ± oxaliplatin (70 percent), irinotecan, or both | 138 | 12.5 | 128 | 11.6 |
Delaunoit T, 2005 | 795 | Irinotecan/FU/LV | NR | NR | 24 | 3.3* |
Oxaliplatin/FU/LV | NR | NR | 24 | 3.3* | ||
Irinotecan/oxaliplatin | NR | NR | 24 | 3.3* | ||
Alberts S, 2005 | 42 | Oxaliplatin/FU/LV | 17 | 40 | 14 | 33 |
Falcone A, 2007 | 122 | Irinotecan/FU/LV | 15 | 12 | 15 | 12 |
122 | Oxaliplatin/irinotecan + FU/LV | 44 | 36 | 44 | 36 | |
Barone C, 2007 | 40 | Irinotecan/FU/LV | 13 | 33 | 13 | 33 |
Ychou M, 2007 | 34 | Oxaliplatin/irinotecan + FU/LV | 28 | 82 | 9 | 27 |
Masi G, 2009 | 196 | Oxaliplatin/irinotecan + FU/LV | 47 | 24 | 37 | 19 |
Do you want to add Medilib to your home screen?